… human serum. We demonstrate the presence of specific glycans in pancreatic cancer serum
… N-linked glycopeptides from normal and pancreatic cancer serum were enriched using two …

… of altered glycosylation of several serum proteins prior to pancreatic cancer diagnosis, …
In summary, we have profiled numerous serum protein glycosylation sites and compared …

… glycosylation related to pancreatic cancer. A few studies on N-glycosylation profiles in
pancreatic cancer have … Here, we use an automated protocol for the analysis of the total serum N-…

… Increased fucosylation can be detected in serum from patients with pancreatic cancer (56), …
To fully exploit glycans clinically it will be vital to fully profile the pancreatic cancer glycome …

… (11, 12) Therefore, in the present study, we investigated the serum N-glycome profiles of
patients with pancreatic cancer and nonmalignant controls to identify potential new biomarkers. …

… In this study, we applied lectin array technology for screening of protein glycosylation
moieties in serum to aid in early diagnosis of pancreatic cancer and precursor lesions. …

… profiling to a normal, immortalized pancreatic duct cell line. Our results revealed major
differences in the N-glycosylation … Pancreatic cancer serum detection using a lectin/glyco-antibody …

… controls, chronic pancreatitis, and pancreatic cancer sera were … Analysis on 13 sample sets
was performed in this study, … N-glycosylation sites in proteins derived from human pancreas …

… one or two, but not all, N-glycosylation sites in a specific glycoprotein. In conclusion, the
analysis shows that pancreatic cancer, and acute pancreatitis are associated with changes in …

… Their glycosylation levels were found to be elevated in pancreatic cancer serum in this study
using a RP HPLC-fraction microarray method 28. Both of these two glycoproteins produced …